These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 22018950
1. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Wang LG, Gu J. Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950 [Abstract] [Full Text] [Related]
3. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E. Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725 [Abstract] [Full Text] [Related]
5. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Yamada A, Horimatsu T, Okugawa Y, Nishida N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, Higurashi T, Yukawa N, Amanuma Y, Kikuchi O, Muto M, Ueno Y, Nakajima A, Chiba T, Boland CR, Goel A. Clin Cancer Res; 2015 Sep 15; 21(18):4234-42. PubMed ID: 26038573 [Abstract] [Full Text] [Related]
6. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis. Zhi ML, Liu ZJ, Yi XY, Zhang LJ, Bao YX. Genet Mol Res; 2015 Dec 22; 14(4):18018-25. PubMed ID: 26782449 [Abstract] [Full Text] [Related]
9. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Int J Cancer; 2010 Jul 01; 127(1):118-26. PubMed ID: 19876917 [Abstract] [Full Text] [Related]
10. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A. Sci Rep; 2017 Mar 06; 7():43393. PubMed ID: 28262692 [Abstract] [Full Text] [Related]
11. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H, Ghanadian S, Pakravan K, Razmara E, Rouhollah F, Mossahebi-Mohammadi M, Babashah S. Life Sci; 2020 Oct 01; 258():118226. PubMed ID: 32771555 [Abstract] [Full Text] [Related]
15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225 [Abstract] [Full Text] [Related]
16. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. Faltejskova P, Bocanek O, Sachlova M, Svoboda M, Kiss I, Vyzula R, Slaby O. Cancer Biomark; 2012 Feb 15; 12(4):199-204. PubMed ID: 23568010 [Abstract] [Full Text] [Related]
18. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer. Lai H, Zhang J, Zuo H, Liu H, Xu J, Feng Y, Lin Y, Mo X. Medicine (Baltimore); 2020 Feb 15; 99(9):e19265. PubMed ID: 32118734 [Abstract] [Full Text] [Related]
20. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients. Wanram S, Klaewkla N, Pinyosri P. Microrna; 2024 Feb 15; 13(1):56-62. PubMed ID: 38231064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]